Mukka Proteins Ltd

Mukka Proteins Ltd

₹ 35.1 -0.40%
03 Jul - close price
About

Incorporated in 2003, It is an animal protein company, primarily engaged in the production of Fish Meal, Fish Oil and Fish Soluble Paste as well as developing alternative proteins such as Black Soldier Fly (BSF) Insect meal in the animal food segment.[1]

Key Points

Leading Fish Meal Manufacturer[1] The company is a leading player in Indian fish protein industry contributing 25-30% to the Indian fish meal and fish oil industry.

  • Market Cap 1,052 Cr.
  • Current Price 35.1
  • High / Low 44.0 / 30.0
  • Stock P/E 15.0
  • Book Value 13.2
  • Dividend Yield 0.00 %
  • ROCE 18.9 %
  • ROE 25.8 %
  • Face Value 1.00

Pros

  • Company has delivered good profit growth of 38.6% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.6%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 38.7 to 49.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Mar 2023 Sep 2023 Dec 2023 Mar 2024
397 421 332 517 257
362 378 294 498 224
Operating Profit 35 43 38 19 32
OPM % 9% 10% 11% 4% 13%
5 -0 6 8 5
Interest 4 7 6 6 7
Depreciation 3 3 3 3 3
Profit before tax 33 33 35 17 27
Tax % 17% 34% 18% 31% -8%
27 22 29 12 29
EPS in Rs 1.03 0.99 1.28 0.48 0.91
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
409 549 604 770 1,177 1,380
385 525 582 723 1,091 1,274
Operating Profit 23 24 22 48 86 105
OPM % 6% 4% 4% 6% 7% 8%
2 8 10 7 8 19
Interest 4 7 8 10 16 25
Depreciation 2 5 8 9 12 12
Profit before tax 19 20 15 36 66 87
Tax % 27% 31% 29% 28% 28% 15%
14 14 11 26 48 74
EPS in Rs 1.10 2.00 2.34
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 28%
3 Years: 32%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 39%
3 Years: 123%
TTM: 62%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 26%
3 Years: 29%
Last Year: 26%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 6 6 6 22 22 30
Reserves 38 51 61 76 126 366
83 142 159 175 262 365
74 95 129 119 166 179
Total Liabilities 201 293 355 392 575 941
49 78 79 83 85 85
CWIP 0 2 4 0 0 0
Investments 8 4 12 21 21 31
144 209 260 289 469 825
Total Assets 201 293 355 392 575 941

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-20 -25 2 5 -57 -150
-23 -28 -14 -11 -2 -48
34 54 13 15 75 266
Net Cash Flow -9 1 2 8 15 68

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 25 23 29 29 38 49
Inventory Days 95 89 106 95 88 136
Days Payable 63 63 71 56 51 44
Cash Conversion Cycle 57 49 64 68 75 141
Working Capital Days 63 76 79 77 88 139
ROCE % 15% 9% 18% 23%

Shareholding Pattern

Numbers in percentages

Mar 2024
73.33%
6.46%
2.00%
18.21%
No. of Shareholders 1,15,928

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents